National Comprehensive Cancer Network

About NCCN

One Week to Register for NCCN 2016 Congress Series™: Lung Cancer in Cleveland

The American Cancer Society (ACS) estimated that 221,200 new cases of lung cancer—the leading cause of cancer death—would be diagnosed in the United States in 2015 with an estimated 158,040 deaths. Accounting for more than 80 percent of all lung cancers, non-small cell lung cancer (NSCLC) occurs primarily in older patients with a median age at diagnosis of 70 years.

On May 17, 2016, the National Comprehensive Cancer Network® (NCCN®) and Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute will host the NCCN 2016 Congress Series™: Lung Cancer to educate clinicians about new therapeutic interventions and agents that have been introduced and new systemic therapies that are available, including some that are especially useful for older patients and for patients with metastatic NSCLC. The Congress will also cover the quickly evolving strategies for lung cancer screening to minimize risk and increase the odds of discovering NSCLC at an early stage while it is still treatable and curable.

Physicians need to know how to assess older patients with NSCLC to determine risk for adverse outcomes from cancer treatment and identify therapeutic options that may be more appropriate for older patients at higher risk.  Recent updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Non-Small Cell Lung Cancer and NCCN Guidelines® for Older Adult Oncology provide recommendations that can assist clinicians in managing their patients with NSCLC.

To view the full agenda and to register for this event, visit: www.cvent.com/d/7fq4y8.